A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma
Abstract
No abstract availableFunding Information
- SingHealth and Duke-NUS Research (SDC/021/2015)
- A*STAR Biomedical Research Council
- National Medical Research Council Stratified Medicine Programme Office (SMPO201302)
This publication has 12 references indexed in Scilit:
- The Landscape of Somatic Genetic Alterations in Metaplastic Breast CarcinomasClinical Cancer Research, 2017
- Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneityLaboratory Investigation, 2016
- MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expressionJournal of Clinical Pathology, 2016
- An approach to the diagnosis of spindle cell lesions of the breastHistopathology, 2015
- Phyllodes tumours of the breast: a consensus reviewHistopathology, 2015
- Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progressionThe Journal of Pathology, 2015
- Genomic landscapes of breast fibroepithelial tumorsNature Genetics, 2015
- Genomic Profiling of Advanced-Stage, Metaplastic Breast Carcinoma by Next-Generation Sequencing Reveals Frequent, Targetable Genomic Abnormalities and Potential New Treatment OptionsArchives of Pathology & Laboratory Medicine, 2015
- Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenomaNature Genetics, 2014
- PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA SequencingPLOS ONE, 2014